XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (601,000) $ (989,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 322,000 120,000
Equity compensation expense 17,000 127,000
Change in assets and liabilities:    
Accounts receivable 1,608,000 545,000
Inventories 313,000 347,000
Prepaid expenses and other assets 169,000 (21,000)
Trade payables (104,000) (70,000)
Operating leases 40,000
Accrued liabilities (50,000) 49,000
Net cash (used in) provided by operating activities 1,714,000 108,000
Cash flows from investing activities:    
Purchases of property, plant and equipment (42,000) (274,000)
Net cash (used in) provided by investing activities (42,000) (274,000)
Cash flows from financing activities:    
Receipt for preferred stock issuance 500,000
Repayment of note payable, related party (1,000,000)
Repayment of note payable (42,000) (30,000)
Net advances (repayments) on revolving line of credit (1,832,000) (203,000)
Net cash provided by (used in) financing activities (1,874,000) (733,000)
Net increase (decrease) in cash and cash equivalents (202,000) (899,000)
Cash and cash equivalents at beginning of period 220,000 921,000
Cash and cash equivalents at end of period 18,000 22,000
Supplemental disclosure of cash flow information and noncash investing and financing activities:    
Cash payments for interest 227,000 454,000
Accretion of dividends on preferred stock 86,000 70,000
Common stock issued in exchange for assets acquired 6,250,000
Allocation of proceeds from preferred stock financing to the issuance of warrants for preferred stock 814,000
Reclassification of advances upon issuances of preferred stock 1,500,000
Conversion of advance received from investors into common stock 1,050,000
Common stock issued in exchange for rent due to Icy Melon $ 182,000